SCIENTECH2291.HKValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Deeply Undervalued” zone.
As of Oct 16, 2026, SCIENTECH (2291.HK) trades at a P/E of 19.50x, P/B of 1.99x, P/S of 7.97x, and a dividend yield of 4.26%.
Longitudinal percentile comparison: P/E sits at the 18th percentile over the trailing 10Y window (vs. 21st percentile over 3Y); P/B sits at the 11th percentile over the trailing 10Y window (vs. 15th percentile over 3Y); P/S sits at the 12th percentile over the trailing 10Y window (vs. 15th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 60th percentile within its industry and the 72nd percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 5.36%, ranking at the 94th percentile over the trailing 20Y window.
Cross-checking P/E against P/B, the two percentiles sit within 7.0 points of each other — a consistent signal from both angles. The P/E percentile sits lower within its industry than across the market as a whole — relatively cheaper next to direct peers. Of the 5.36% total shareholder yield, 4.26% is paid out as dividends and roughly 1.10% is implied to come from buybacks — both channels are meaningfully in play. SCIENTECH operates in the Other Pharmaceuticals and Medical Services sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: HKG: 2291 · SEHK: 2291 · 2291
Want the full picture on whether SCIENTECH (2291.HK) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 19.50 | ||||||
| P/B (MRQ) | 1.99 | ||||||
| P/S (TTM) | 7.97 | ||||||
| Dividend Yield | 4.26% | ||||||
| Buyback + Div Yield | 5.36% |